| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8595684 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 6 Pages |
Abstract
Labetalol- and nicardipine-continuous infusions were comparable in the studied safety and efficacy outcomes including time at goal and BP variability. Further prospective studies are needed to validate these safety and efficacy findings and to assess clinical outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Jason P. PharmD, BCPS, Patrick G. PharmD, BCPS,